Developing nanocarriers for oral drug delivery is often
hampered
by the dilemma of balancing mucus permeation and epithelium absorption,
since huge differences in surface properties are required for sequentially
overcoming these two processes. Inspired by mucus-penetrating viruses
that universally possess a dense charge distribution with equal opposite
charges on their surfaces, we rationally designed and constructed
a poly(carboxybetaine)-based and polyguanidine-inserted cationic micelle
platform (hybrid micelle) for oral drug delivery. The optimized hybrid
micelle exhibited a great capacity for sequentially overcoming the
mucus and villi barriers. It was demonstrated that a longer zwitterionic
chain was favorable for mucus diffusion for hybrid micelles but not
conducive to cellular uptake. In addition, the significantly enhanced
internalization absorption of hybrid micelles was attributed to the
synergistic effect of polyguanidine and proton-assisted amine acid
transporter 1 (PAT1). Moreover, the retrograde pathway was mainly
involved in the intracellular transport of hybrid micelles and transcytosis
delivery. Furthermore, the prominent intestinal mucosa absorption
in situ and in vivo liver distribution of the oral hybrid micelle
were both detected. The results of this study indicated that the hybrid
micelles were capable of conquering the intestinal mucosal barrier,
having a great potential for oral application of drugs with poor oral
bioavailability.